Long-term progression of Alzheimer's disease in patients under antidementia drugs

Alzheimer's and Dementia

Volumn 7, Issue 6, 2011, Pages 579-592

  Gillette Guyonnet, Sophie ^a,b,c   Andrieu, Sandrine ^a,b,c,d   Nourhashemi, Fati ^a,b,c   Gardette, Virginie ^b,c,d   Coley, Nicola ^b,c   Cantet, Christelle ^a,b,c   Gauthier, Serge ^e   Ousset, Pierre Jean ^a,b,c   Vellas, Bruno ^a,b,c  

^a CHU PURPAN   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE TOULOUSE   (France)

^d TOULOUSE UNIVERSITY HOSPITAL   (France)

^e MCGILL UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; Antidementia drugs; Behavior disorders; Cognitive decline; Cohort study; Current medical practice; Functional incapacity; Institutionalization; Mortality; REAL.FR

Indexed keywords

NOOTROPIC AGENT;

AGED; ALZHEIMER DISEASE; ARTICLE; COGNITION; DAILY LIFE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; INSTITUTIONALIZATION; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MORTALITY; NEUROPSYCHIATRY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RATING SCALE; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; AGED; ALZHEIMER DISEASE; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; NOOTROPIC AGENTS;

EID: 80755156409     PISSN: 15525260     EISSN: 15525279     Source Type: Journal    
DOI: 10.1016/j.jalz.2011.02.009     Document Type: Article

References (39)

1. P.R. Solomon, and C.A. Murphy Early diagnosis and treatment of Alzheimer's disease Expert Rev Neurother 8 2008 769 780 (Pubitemid 351656828)
2. J. Cohen-Mansfield, and J.E. Mintzer Time for change: the role of nonpharmacological interventions in treating behavior problems in nursing home residents with dementia Alzheimer Dis Assoc Disord 19 2005 37 40 (Pubitemid 40940997)
3. V.S. Sierpina, M. Sierpina, J.A. Loera, and L. Grumbles Complementary and integrative approaches to dementia South Med J 98 2005 636 645 (Pubitemid 40848103)
4. J. Birks Cholinesterase inhibitors for Alzheimer's disease Cochrane Database Syst Rev 2006 CD005593
5. K. Ito, S. Ahadieh, B. Corrigan, J. French, T. Fullerton, T. Tensfeldt Alzheimer's Disease Working Group Disease progression meta-analysis model in Alzheimer's disease Alzheimer's Dement 6 2010 39 53
6. J.C. Morris, A. Heyman, R.C. Mohs, J.P. Hugues, G. Fillenbaum, E.D. Mellits, and C. Clark The Consortium to Establish a Registry for Alzheimer's disease (CERAD). Part I: clinical and neuropsychological assessment of Alzheimer's disease Neurology 39 1989 1159 1165 (Pubitemid 19239715)
7. Y. Stern, M. Folstein, M. Albert, M. Richards, L. Miller, and F. Bylsma Multicenter study of predictors of disease course in Alzheimer disease (the 'predictors study'). I. Study design, cohort description, and intersite comparisons Alzheimer Dis Associ Disord 7 1993 3 21 (Pubitemid 23127936)
8. X. Kurz, M. Broers, J. Scuvée-Moreau, E. Salmon, M. Ventura, J.L. Pepin, R. Dom, G. Franck, and A. Dresse Methodological issues in a cost-of-dementia study in Belgium: the National Dementia Economic Study (NADES) Acta Neurol Belg 99 1999 167 175
9. E. Reynish, F. Cortes, S. Andrieu, C. Cantet, M. Olde Rikkert, and R. Melis The Ictus Study: a prospective longitudinal observational study of 1380 AD patients in Europe. Study design and baseline characteristics of the cohort Neuroepidemiology 29 2007 29 38 (Pubitemid 350191415)
10. G. Livingston, A. Walker, C. Katona, and C. Cooper Antipsychotics and cognitive decline in Alzheimer's disease: the LASER-Alzheimer's disease longitudinal study J Neurol Neurosurg Psychiatry 78 2007 25 29 (Pubitemid 46048258)
11. S. Gillette-Guyonnet, F. Nourhashemi, S. Andrieu, C. Cantet, M. Micas, P.J. Ousset, B. Vellas REAL.FR Group The REAL.FR research program on Alzheimer's disease and its management: methods and preliminary results J Nutr Health Aging 7 2003 91 96 (Pubitemid 36506207)
12. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) 4th ed. 1997 APA Washington, DC
13. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease Neurology 34 1984 939 944 (Pubitemid 14076461)
14. M.F. Folstein, S.E. Folstein, and P.R. Mc Hugh Mini-Mental-Test: a practical method for grading the cognitive state of patient for the clinician J Psychiatr Res 12 1975 189 198
15. W.G. Rosen, R.C. Mohs, and K.L. Davis A new rating scale for Alzheimer's disease Am J Psychiatry 141 1984 1356 1362
16. J.C. Morris The Clinical Dementia Rating (CDR): current version and scoring rules Neurology 43 1993 2412 2414 (Pubitemid 23346995)
17. S. Katz, A.B. Ford, R.W. Moskowitz, B.A. Jackson, and M.W. Jaffe The index of ADL: a standardized measure of biological and psychosocial function JAMA 185 1963 914 919
18. J.L. Cummings, M. Mega, K. Gray, S. Rosenberg-Thompson, D.A. Carusi, and J. Gornbein The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia Neurology 44 1994 2308 2314 (Pubitemid 24382728)
19. S.L. Zeger, and K.Y. Liang An overview of methods for the analysis of longitudinal data Stat Med 11 1992 1825 1839 (Pubitemid 23015633)
20. C.M. Clark, L. Sheppard, C.G. Fillenbaum, D. Galasko, J.C. Morris, E. Koss, R. Mohs, and A. Heyman Variability in annual Mini Mental State Examination score in patients with probable Alzheimer's disease: a clinical perspective of data from the Consortium to Establish a Registry for Alzheimer's disease Arch Neurol 56 1999 857 862 (Pubitemid 29318912)
21. B. Vellas, S. Andrieu, C. Cantet, J.F. Dartigues, S. Gauthier REAL.FR group Long-term changes in ADAS-cog: what is clinically relevant for disease modifying trials in Alzheimer? J Nutr Health Ageing 11 2007 338 341 (Pubitemid 47121935)
22. Zhu CW, Livote EE, Kahle-Wrobleski K, Scarmeas N, Albert M, Brandt J, Blacker D, Sano M, Stern Y. Longitudinal medication usage in Alzheimer disease patients. Alzheimer Dis Assoc Disord (in press).
23. P. Behl, T.L. Stefurak, and S.E. Black Progress in clinical neurosciences: cognitive markers of progression in Alzheimer's disease Can J Neurol Sci 32 2005 140 151 (Pubitemid 40839956)
24. M.E. Soto, S. Andrieu, C. Arbus, M. Ceccaldi, P. Couratier, and T. Dantoine Rapid cognitive decline in Alzheimer's disease. Consensus Paper J Nutr Health Ageing 12 2008 703 713
25. L. Han, M. Cole, F. Bellavance, J. McCusker, and F. Primeau Tracking cognitive decline in Alzheimer's disease using the Mini-Mental State Examination: a meta-analysis Int Psychogeriatr 12 2000 231 247 (Pubitemid 30490970)
26. R.G. Stern, R.C. Mohs, M. Davidson, J. Schmeidler, J. Silverman, E. Kramer-Ginsberg, T. Searcey, L. Bierer, and K.L. Davis A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration Am J Psychiatry 151 1994 390 396 (Pubitemid 24081459)
27. C. Holmes, and S. Lovestone Long-term cognitive and functional decline in late onset Alzheimer's disease: therapeutic implications Age Aging 32 2003 200 204 (Pubitemid 36372428)
28. F. Di lulio, K. Palmer, C. Blundo, A.R. Casini, W. Gianni, C. Caltagirone, and G. Spalletta Occurrence of neuropsychiatric symptoms and psychiatric disorders in mild Alzheimer's disease and mild cognitive impairment subtypes Int Psychogeriatr 22 2010 629 640
29. S.E. Starkstein, R. Jorge, R. Mizrahi, and R.G. Robinson A prospective longitudinal study of apathy in Alzheimer's disease J Neurol Neurosurg Psychiatry 77 2006 8 11 (Pubitemid 43022682)
30. G. Waldemar, S. Gauthier, R. Jones, D. Wilkinson, J. Cummings, and O. Lopez Effect of donepezil on emergence of apathy in mild to moderate Alzheimer's disease Int J Geriatr Psychiatry 26 2011 150 157
31. N. Scarmeas, J. Brandt, D. Blacker, M. Albert, G. Hadjigeorgiou, B. Dubois, D. Devanand, L. Honig, and Y. Stern Disruptive behavior as a predictor in Alzheimer disease Arch Neurol 64 2007 1755 1761 (Pubitemid 350254938)
32. A.M. Brickman, A. Riba, K. Bell, K. Marder, M. Albert, J. Brandt, and Y. Stern Longitudinal assessment of patient dependence in Alzheimer Disease Arch Neurol 59 2002 1304 1308 (Pubitemid 34856385)
33. K. Stavitski, A.M. Brickman, N. Scarmeas, R.L. Torgan, M.X. Tang, M. Albert, J. Brandt, D. Blacker, and Y. Stern The progression of cognition, psychiatric symptoms and functional abilities in dementia with lewy bodies and Alzheimer disease Arch Neurol 63 2006 1450 1456 (Pubitemid 44547558)
34. M. Sarazin, Y. Stern, C. Berr, A. Riba, M. Albert, J. Brandt, and B. Dubois Neuropsychological predictors of dependency in patients with Alzheimer disease Neurology 64 2005 1027 1031 (Pubitemid 40388456)
35. K. Yaffe, P. Fox, R. Newcorner, L. Sands, K. Lindquist, K. Dane, and K.E. Covinsky Patient and caregiver characteristics and nursing home placement in patients with dementia JAMA 287 2002 2090 2097 (Pubitemid 34437344)
36. H.R. Brunnström Cause of death in patients with dementia disorders Eur J Neurol 16 2009 488 492
37. N. Coley, V. Gardette, O. Toulza, S. Gillette-Guyonnet, C. Cantet, F. Nourhashemi, S. Andrieu, A. Grand, and B. Vellas Predictive factors of attrition in a cohort of Alzheimer disease patients Neuroepidemiology 31 2008 69 79
38. C.M. Persson, A.K. Wallin, S. Levander, and L. Minthon Changes in cognitive domains during three years in patients with Alzheimer's disease treated with donepezil BMC Neurology 9 2009 7
39. A. Bruandet, F. Richard, S. Bombois, C.A. Maurage, V. Deramecourt, F. Lebert, P. Amouyel, and F. Pasquier Alzheimer disease with cerebrovascular disease and vascular dementia: clinical features and course compared with Alzheimer disease J Neurol Neurosurg Psychiatry 80 2009 133 139